BioCentury
ARTICLE | Clinical News

Vascular Lipid Removal: LIPD began an Australian Phase I trial in 10 volunteers of its VLR human plasma delipidation system, which filters and delipidates plasm

May 13, 2002 7:00 AM UTC

Lipid Sciences Inc. (LIPD), Pleasanton, Calif. Product: Vascular Lipid Removal (VLR) system Business: Cardiovascular Therapeutic category: Blood substitute Target: Lipids Description: Technology for d...